💊FDA PHARMA TODAY

By Drugs, Pharmaceutical

💊FDA PHARMA TODAY

SUMITOMO DAINIPPON PHARMA CO., LTD. Filed Patent Infringement Lawsuits Regarding LATUDA in the United States

SUMITOMO DAINIPPON PHARMA Co., Ltd

http://www.ds-pharma.com/ir/news/pdf/ene20180214.1.pdf

Sumitomo Dainippon Pharma and Nitto Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN

SUMITOMO DAINIPPON PHARMA Co., Ltd

http://www.ds-pharma.com/ir/news/pdf/ene20180214.2.pdf

More from tokioX :

  1. Takeda Pharma Transfers 18 Pharmaceutical Businesses: Hypera Pharma
  2. 💊Sumitomo Dainippon Pharma Completes Manufacturing Plant for Regenerative Medicine & Cell Therapy
  3. 💊SUMITOMO DAINIPPON PHARMA CO., LTD. Filed Additional Patent Infringement Lawsuit Regarding LATUDA in the United States
  4. 💊Sumitomo Dainippon Pharma Announces an Atypical Antipsychotic LONASEN is Now Available in China
  5. 💊FDA PHARMA today
  6. 💊Notice Regarding Implementation of New Drug Discovery Program “JOINUS” Using Drug Repositioning Compound Libraries by Astellas Pharma, Mitsubishi Tanabe Pharma and Daiichi Sankyo
  7. 💊Mitsubishi Tanabe Pharma Corporation] Notice regarding acquisition of manufacturing and sales approval for Rupafin tablets Allergy treatment agent with new mechanism of action shows strong effectiveness with dual action (anti-PAF and antihistamine action)  20170927